Tilray Medical has commercially launched its first medical cannabis product, Tilray Oral Solution CBD100, in Panama through Farmacias Arrocha. This launch marks a key step in expanding patient access to regulated, pharmaceutical-grade medical cannabis in Latin America. The product is manufactured in Portugal under strict EU-GMP standards and supports Panama's emerging medical cannabis framework. Tilray Medical aims to broaden access across over 20 countries, advancing patient care and regulatory compliance in global markets.
Tilray Brands, a global leader in cannabis and consumer packaged goods, will announce its financial results for the fourth quarter and full fiscal year ending May 31, 2026, on July 28, 2026, after market close. The company will hold a live conference...
BrewDog Waterloo, England's largest pub owned by Tilray Brands, is set to host a major watch party for the England vs Argentina semifinal. The event promises an electric atmosphere with giant screens and passionate fans. Tilray's £1 million bar tab p...
Breckenridge Distillery, a leading craft distillery and subsidiary of Tilray Brands, has introduced Breck Vodka Seltzer, a new ready-to-drink beverage line featuring four flavors: lime, grapefruit, peach, and tropical. Each seltzer contains 5% alcoho...
